AI-powered search
Try Polaris, our new AI-powered search!

What are the advantages of JAK therapy vs. monoclonal antibody therapy for atopic dermatitis?

Featuring Matthew Zirwas, MD |

Associate Professor of Dermatology 
Ohio University Heritage College of Medicine 
Athens, OH

| Published November 17, 2021

More from this series

Who is a good candidate for lebrikizumab?

Atopic Dermatitis

Who is a good candidate for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the dosing regimen for lebrikizumab?

Atopic Dermatitis

What is the dosing regimen for lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

What is the safety profile of lebrikizumab?

Atopic Dermatitis

What is the safety profile of lebrikizumab?

Featuring Raj Chovatiya, MD, PhD, MSCI

Related Media

Powered by Polaris TM